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Summary
Mutations in WNK1 and WNK4 kinase genes have been
shown to cause a human hereditary hypertensive disease,
pseudohypoaldosteronism type II (PHAII). We previously
discovered that WNK kinases phosphorylate and activate
OSR1/SPAK kinases that regulate renal SLC12A family
transporters such as NKCC2 and NCC, and clarified that the
constitutive activation of this cascade causes PHAII. WNK3,
another member of the WNK kinase family, was reported to
be a strong activator of NCC/NKCC2 when assayed in
Xenopus oocytes, suggesting that WNK3 also plays a major
role in regulating blood pressure and sodium reabsorption in
the kidney. However, it remains to be determined whether
WNK3 is in fact involved in the regulation of these
transporters in vivo. To clarify this issue, we generated and
analyzed WNK3 knockout mice. Surprisingly,
phosphorylation and expression of OSR1, SPAK, NKCC2
and NCC did not decrease in knockout mouse kidney under
normal and low-salt diets. Similarly, expression of epithelial
Na channel and Na/H exchanger 3 were not affected in
knockout mice. Na+ and K+ excretion in urine in WNK3
knockout mice was not affected under different salt diets.
Blood pressure in WNK3 knockout mice was not lower under
normal diet. However, lower blood pressure was observed in
WNK3 knockout mice fed low-salt diet. WNK4 and WNK1
expression was slightly elevated in the knockout mice under
low-salt diet, suggesting compensation for WNK3 knockout
by these WNKs. Thus, WNK3 may have some role in the
WNK-OSR1/SPAK-NCC/NKCC2 signal cascade in the
kidney, but its contribution to total WNK kinase activity
may be minimal.
 2011. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
Pseudohypoaldosteronism type II (PHAII) is an autosomal-
dominant disease characterized by hypertension due to
increased renal salt reabsorption, hyperkalemia and metabolic
acidosis (Gordon, 1986; Schambelan et al., 1981; Achard et al.,
2001). Mutations in with-no-lysine kinase 1 (WNK1) and with-
no-lysine kinase 4 (WNK4) have been reported to cause PHAII
(Wilson et al., 2001). We generated WNK4D561A/+ knock-in
mice, an ideal mouse model of PHAII, and observed increased
phosphorylation of oxidative stress-responsive kinase-1 (OSR1),
STE20/SPS1-related proline/alanine-rich kinase (SPAK) and
thiazide-sensitive Na-Cl co-transporter (NCC) (Yang, S. S. et
al., 2007). We previously demonstrated in in vitro experiments
that WNK1 and WNK4 phosphorylated and activated OSR1 and
SPAK kinases, and that OSR1 and SPAK could phosphorylate
NCC (Moriguchi et al., 2005; Vitari et al., 2005; Vitari et al.,
2006; Richardson et al., 2008). Furthermore, Pacheco-Alvarez et
al. reported that phosphorylation of NCC at Thr 53 and 58, and at
Ser 71 was important for NCC function in Xenopus oocytes
(Pacheco-Alvarez et al., 2006), and we showed that
phosphorylated NCC is concentrated on the apical membranes
of distal convoluted tubules in the WNK4D561A/+ knock-in mice,
which suggests that phosphorylation may also be important for
intracellular localization of NCC (Yang, S. S. et al., 2007). Based
on the above evidence, we postulated that WNK, OSR1/SPAK
and NCC constitute a signal cascade in the in vivo kidney, which
is important for NaCl homeostasis and blood pressure regulation.
Recently, we mated WNK4D561A/+ knock-in mice with SPAK and
OSR1 kinase-dead knock-in mice, in which the T-loop Thr
residues in SPAK (Thr 243) and OSR1 (Thr 185) were mutated to
Ala to prevent activation by WNK kinases (Rafiqi et al., 2010). In
these triple knock-in mice, PHAII phenotypes and increased
phosphorylation of NCC were completely corrected (Chiga et al.,
2011). Based on the definitive genetic data, we clearly
established the presence of the WNK-OSR1/SPAK-NCC kinase
cascade in the in vivo kidney.
Although the signal cascade was established, it remains
unclear which WNK kinase is responsible in the kidney. It is
also uncertain whether a single dominant WNK kinase is present
in each different type of cell, or whether multiple WNKs are
present in the same cells and function as a WNK kinase complex,
as postulated by Yang, C. L. et al. (Yang, C. L. et al., 2007). In
fact, in addition to WNK1 and WNK4, whose mutations cause
PHAII, WNK3 mRNA expression was reported to be present in
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the kidney (Holden et al., 2004). Therefore, although WNK3
mutation has not been observed in PHAII, WNK3 could be an
important component of WNK kinase-mediated signal cascade in
kidney. Previous in vitro data found that WNK3 regulates
SLC12A cotransporters. WNK3 was shown to be an activator of
Na-K-Cl cotransporter (NKCC1 and 2) and NCC (Kahle et al.,
2005; Rinehart et al., 2005; Yang, C. L. et al., 2007; San-
Cristobal et al., 2008; Ponce-Coria et al., 2008; Glover et al.,
2009; Cruz-Rangel et al., 2011), and a repressor of K-Cl
cotransporters (KCC 1-4) (Kahle et al., 2005; de Los Heros et al.,
2006), when co-expressed in Xenopus laevis oocytes. Similar to
WNK1 and WNK4, WNK3 was found to phosphorylate SPAK in
Xenopus laevis oocytes (Ponce-Coria et al., 2008).
Previously, WNK4 hypomorphic mice and WNK1
heterozygous mice reportedly showed low blood pressure (Ohta
et al., 2009; Zambrowicz et al., 2003). Therefore, we aimed to
determine the contribution of WNK3 to WNK-mediated kidney
functions by generating WNK3 knockout mice. The data
obtained suggest that WNK3 may not play a major role in the
WNK kinase cascade in the kidney.
Results
Generation of WNK3 knockout mice
In order to generate WNK3 knockout mice, we planned to delete
exon 2 (Fig. 1A), as exon 2 contains the catalytic domain of
mouse WNK3 (Holden et al., 2004; Verissimo et al., 2006). We
crossed chimeric mice from recombinant ES clones with C57BL/
6 mice to produce WNK3 (flox/+) mice. The generation of
WNK3 (flox/+) mice was verified by PCR (Fig. 1B). Next, to
delete exon 2 from the Wnk3 gene, we crossed WNK3 (flox/+)
female mice with Cre recombinase transgenic male mice. The
Cre-mediated excision of exon 2 and Neo cassette was verified
by PCR, as shown in Fig. 1C. The absence of WNK3 protein was
confirmed by immunoblotting in brain and testis (Fig. 1D).
However, due to the low level of WNK3 protein expression in the
kidney, WNK3 was not detected by immunoblotting, even in
wild-type mouse kidney. To verify that WNK3 is also disrupted
in the kidney, we performed RT-PCR of WNK3 and confirmed
the absence of WNK3 mRNA in the kidneys of WNK3 knockout
mice (Fig. 1E).
Segmental expression of WNK3 along mouse nephron
First, we aimed to determine where WNK3 is expressed along the
mouse nephron, as we had to identify the transporters present in
the segment where WNK3 is expressed. It was previously
reported that, on immunofluorescence, WNK3 is present in all
nephron segments (Rinehart et al., 2005). However, because the
same antibody did not work both in immunofluorescence and
immunoblotting in our hand, we performed laser capture
microdissection (LCM) and RT-PCR in order to confirm
segmental expression of WNK3 along nephron. As shown in
Fig. 2, we confirmed that WNK3 is expressed in proximal
tubules, thick ascending limb of Henle’s loop (TAL), distal
convoluted tubules (DCT) and collecting ducts, where Na/H
exchanger 3 (NHE3), NKCC2, NCC and epithelial Na channel
(ENaC) are expressed, respectively.
Fig. 1. Generation of WNK3 knockout mice. (A) Targeting strategy for Wnk3 gene interruption. The diagram shows the targeting construct, the wild-type WNK3
locus, and the targeted locus before and after Cre recombination. Three loxPs were inserted to flank exon 2 and the LacZ-Neo-selective marker. Exon 2 was deleted
by mating the flox mice with CAG promoter Cre recombinase mice. (B) Verification of homologous recombination by PCR of genomic DNA derived from tails of
mice. The primer set is indicated by dotted arrows in A. The 227-bp band and 339-bp band represent the wild-type allele and flox allele, respectively. (C) Genotyping
PCR after Cre recombination, using a primer set indicated by solid arrows in A. A 516-bp PCR product was specific to the mutant allele. (D) Immunoblot of brain,
kidney and testis homogenates probed with anti-WNK3 antibody. Absence of WNK3 protein in WNK3 knockout mouse was confirmed by immunoblotting in brain
and testis. WNK3 was not detected by immunoblotting, even in wild-type mouse kidney, due to the low level of WNK3 protein expression in the kidney. (E) RT-PCR
of brain, kidney and testis of wild-type and WNK3 knockout mice.
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Blood and urine analysis
We observed no obvious differences between the WNK3
knockout mice and wild-type littermates in survival, gross
physical appearance and organ morphology. There were no
significant differences in the plasma K+ and HCO{3 levels
(Table 1). Urine volume and urinary excretion of Na+ and K+
under normal conditions were not significantly affected in WNK3
knockout mice. To more thoroughly characterize the phenotypes,
we fed WNK3 knockout and wild-type mice low-salt (0.01%
NaCl) and high-salt (4% NaCl) diets, and monitored urinary Na+
and K+ excretion, particularly focusing on the transition periods
while changing diets. However, as shown in Fig. 3A–C, sodium
excretion in the WNK3 knockout mice did not change during the
experimental period.
Blood pressure
We used a tail-cuff system to measure blood pressure. As shown in
Fig. 4A, blood pressure inWNK3 knockout mice did not show any
significant differences when compared with wild-type mice under
normal diet (109.761.6 vs. 111.261.6 mmHg, knockout: n511,
wild-type: n514). However, when mice were fed with low-salt
diet, blood pressure in WNK3 knockout mice was lower compared
with wild-type mice (105.861.1 vs. 110.760.7 mmHg, knockout:
n511, wild-type: n59, P,0.01) (Fig. 4B).
Expression and phosphorylation of NCC and NKCC2 were not
affected in WNK3 knockout mouse kidney
WNK3 reportedly activates NCC and NKCC2 function when co-
expressed in Xenopus oocytes. Therefore, we investigated
whether expression and phosphorylation of NCC and NKCC2
were decreased in the kidneys of WNK3 knockout mice.
However, as shown in Fig. 5A–B, we could not see any
significant difference in the protein abundance or the
magnitude of phosphorylation of NKCC2 and NCC between
WNK3 knockout and wild-type mice under a normal diet. Next,
to investigate whether phosphorylation of OSR1 and SPAK was
lower due to an absence of WNK3, we examined phosphorylation
of OSR1 at 325S and SPAK at 380S, phosphorylation sites for
WNK kinases, using phospho-specific antibodies. As shown in
Fig. 5C–D, phosphorylation of OSR1 and SPAK at their WNK
phosphorylation sites was not lower in kidneys from WNK3
knockout mice.
Furthermore, we examined the phosphorylation status of NCC
and NKCC2 in WNK3 knockout mice under low-salt diet, since
blood pressure in WNK3 knockout mice was lower, when mice
were fed with low-salt diet. However, even under low-salt diet,
WNK3 knockout mice did not show decreased phosphorylation
of either NCC or NKCC2, when compared with wild-type mice
(Fig. 6A–B). These results indicated that WNK3 does not play a
major role in regulation of NCC and NKCC2 in vivo mouse
kidney, in contrast to several over-expression studies in Xenopus
oocytes. Phosphorylation of OSR1 and SPAK at their WNK
phosphorylation sites was not lower in kidneys from WNK3
knockout mice, even under low-salt diet (Fig. 6C–D).
Expression of NHE3 and c-ENaC in the kidneys of WNK3
knockout mice was not significantly different from that in wild-
type mice (supplementary material Fig. S1).
Expression levels of WNK4 were elevated in kidneys of WNK3
knockout mice
The WNK kinase family phosphorylates and activates OSR1 and
SPAK, and activated OSR1 and SPAK kinases phosphorylate
NCC. We hypothesized that other WNKs could compensate for
the absence of WNK3 in the kidney. To examine this hypothesis,
we examine the expression levels of WNK1 and WNK4 in the
kidneys of WNK3 knockout mice. As shown in Fig. 7A–B, we
found that WNK4 expression was slightly but significantly
elevated in kidneys from WNK3 knockout mice, as compared to
those from wild-type mice. We also examined WNK1 and
WNK4 expression in WNK3 knockout mice fed low-salt diet, as
compensation would become clearer when the WNK-OSR1/
SPAK-NCC phosphorylation cascade is activated (Chiga et al.,
2008). As expected, under low-salt diet, both WNK1 and WNK4
expression increased significantly in kidneys from WNK3
knockout mice, as compared to wild-type mice (Fig. 7C–D).
These results indicate that increased expression of WNK1 and
WNK4 compensate for the absence of WNK3 in kidneys from
WNK3 knockout mice.
Discussion
One of the major issues in hypertension research is regulation of
renal sodium transporters that control sodium reabsorption in the
Fig. 2. Segmental expression of WNK3 along mouse nephron. Primers for
NHE3, NKCC2, NCC and ENaC were used as markers for each segment.
WNK3 was positive in proximal tubules, thick ascending limb of Henle’s loop,
distal tubules and collecting ducts of wild type mouse. As a negative control,
distal tubules and total kidney homogenate from WNK3 knockout mouse were
used. PT, proximal tubule; TAL, thick ascending limb of Henle’s loop; DCT,
distal convoluted tubule; CD, collecting duct.
Table 1. Biochemical analysis of blood from wild-type and
WNK3 knockout mice
Wild type
(n59)
WNK3
knockout (n510) P Value
Na+ (mmol/l) 145.861.7 144.962.0 0.34
K+ (mmol/l) 4.760.4 4.960.3 0.17
Cl2 (mmol/l) 113.161.1 111.961.4 0.07
HCO{3 (mmol/l) 23.661.4 23.861.1 0.78
pH (venous) 7.3660.02 7.3560.03 0.41
Values in mean 6 SD.
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kidney. NKCC2 and NCC are kidney-specific members of the
SLC12A family of electroneutral cation-chloride co-transporters
(Haas and Forbush, 1998; Gamba, 2005). They have been shown
to play an important role in regulation of blood pressure and
sodium reabsorption in the kidney.
Through analyses using genetically engineered mice, we have
established the existence of the WNK-OSR1/SPAK-NCC kinase
cascade in the in vivo kidney (Yang, S. S. et al., 2007; Chiga et al.,
2008; Chiga et al., 2011; Ohta et al., 2009). To date, several
physiological regulators ofWNK-OSR1/SPAK-NCC phosphorylation
cascade have been reported. We have reported that the WNK-OSR1/
SPAK-NCC cascade is activated by low-salt diet and inhibited by
high-salt diet, mainly via the action of aldosterone (Chiga et al., 2008).
Angiotensin II has also been shown to be a regulator of their
phosphorylation (San-Cristobal et al., 2009; Talati et al., 2010; van der
Lubbe et al., 2011). Thus, WNK-OSR1/SPAK-NCC is a regulator of
NaCl homeostasis in the kidney through the renin-angiotensin-
aldosterone system. Another vasoactive hormone, vasopressin, was
shown to regulate this cascade (Pedersen et al., 2010). We recently
demonstrated that insulin is another potent regulator of the WNK-
OSR1/SPAK-NCC phosphorylation cascade in the kidney (Sohara et
al., 2011). This discovery is important when considering mechanisms
of salt-sensitive hypertension in hyperinsulinemic patients, such as
those with metabolic syndrome. Moreover, Vallon et al. and Naito et
al. reported that potassium intake and extracellular potassium ions,
respectively, regulate this cascade (Vallon et al., 2009; Naito et al.,
2010). Taken together, these reports indicate that the WNK-OSR1/
SPAK-NCC phosphorylation cascade is very important in kidney, not
only for the pathogenesis of PHAII, but also for the homeostatic
regulation of sodium, potassium, and blood pressure under various
pathophysiological conditions.
Similar to NCC, WNKs, OSR1 and SPAK reportedly regulate
NKCC2. OSR1 and SPAK kinases interact with an RFQVmotif on
NKCC2 and directly phosphorylate NKCC2 in in vitro kinase
assays (Moriguchi et al., 2005; Richardson et al., 2008; Richardson
et al., 2011). In addition to OSR1 and SPAK, reduced expression
of WNK1 by siRNA inhibits endogenous NKCC1 activity in HeLa
cells, measured by 86Rb influx assays (Anselmo et al., 2006).
WNK3 is another WNK kinase that is reported to regulate NKCC2
as well as NCC. Rinehart et al. reported that WNK3 increases
NKCC2 phosphorylation at Thr-184 and Thr-189 residues, which
had been identified to be necessary for vasopressin-mediated
plasma membrane translocation and activation of NKCC2 in
Xenopus laevis oocytes (Rinehart et al., 2005). In addition,
overexpression of WNK3 in Xenopus laevis oocytes leads to the
activation of NKCC2, which is dependent upon the interaction of
SPAK and OSR1 with one of the three RFx[V/I]-motifs that are
present in WNK3 (Ponce-Coria et al., 2008; Richardson and
Alessi, 2008). Several other groups have reported that co-
expression of NCC with WNK3 in Xenopus laevis oocytes
increased its transport activity (Rinehart et al., 2005; Yang, C. L.
et al., 2007; San-Cristobal et al., 2008; Glover et al., 2009; Cruz-
Rangel et al., 2011). Therefore, in the kidney, it was expected that
WNK3 could regulate sodium reabsorption along the nephron by
activating NCC and NKCC2 via phosphorylation of OSR1 and
SPAK.
Fig. 3. Urinary excretion of Na+ and
K+ in WNK3 knockout mice. There
were no significant differences in urine
volume (A), urinary Na+ excretion
(B) or K+ excretion (C) between WNK3
knockout mice (squares, n58) and their
wild-type littermates (circles, n58). On
day 0, mice were switched from low-salt
diet (0.01% NaCl) to high-salt diet
(4.0% NaCl). Before switching diet,
mice were fed low-salt diet for 1 week.
n.s. not significant.
Fig. 4. Lower blood pressure in
WNK3 knockout mice fed low-salt
diet. (A) Blood pressure in WNK3
knockout mice under normal diet. Blood
pressure was measured using a tail-cuff
system. WNK3 knockout mice (n59)
did not show significantly decreased
systolic blood pressure, as compared to
their wild-type littermates (n514).
(B) Blood pressure in WNK3 knockout
mice (n511) under low-salt diet. WNK3
knockout mice showed lower blood
pressure, as compared to their wild-type
littermates (n59). *P,0.05. n.s.
not significant.
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Recently, we re-evaluated the immunolocalization of WNK4
along the mouse nephron. In this study, we confirmed that WNK4
is present in DCT, collecting duct and other segments of the
nephron, but not in TAL, where NKCC2 and SPAK are present
(Ohno et al., 2011). The lack of WNK4 protein in TAL is
consistent with our observation that increased phosphorylation of
NKCC2 is not observed in WNK4 knock-in mice (manuscript in
preparation), and the fact that PHAII is sensitive to thiazide, but
not to furosemide. This indicates that activation of furosemide-
sensitive NKCC2 is not observed in PHAII caused by WNK1 or
WNK4 mutation, indicating that WNK1 and WNK4 may not play
a major role in regulation of NKCC2 in the kidney, although
WNK1 phosphorylates NKCC2 in in vitro kinase assays
(Anselmo et al., 2006). Therefore, another WNK kinase could
be present in TAL to regulate SPAK and NKCC2. This suggests
that WNK3 is a regulator of NKCC2 in the kidney.
In this study, we successfully generated WNK3 knockout mice
and analyzed their renal phenotype. However, in contrast to data
obtained in the Xenopus oocytes system and our expectation that
WNK3 is a major regulator of NKCC2, WNK3 knockout mice
did not show any decrease in expression and phosphorylation of
NKCC2 and NCC. Indeed, urinary excretion of Na+ and K+ was
not significantly affected in WNK3 knockout mice, even though
we focused on the transition periods when changing sodium diets.
These results suggest that WNK3 is not a powerful regulator of
NKCC2 and NCC in the kidney, unlike in Xenopus oocytes.
There are several possible explanations as to why expression
and phosphorylation of NKCC2 and NCC were not lower in
WNK3 knockout mouse kidney. It is possible that the expression
level of WNK3 in individual tubular cells was too low to
contribute to the overall WNK kinase activity. Our immunoblot
data clearly showed that WNK3 protein abundance in kidney was
below the detection limit. RT-PCR using dissected nephron
segments did not show the presence of preferential expression
sites for WNK3 along the nephron. These results suggest that
WNK3 does not have a specific role in the kidney, in contrast to
the role of WNK4 and kidney-specific WNK1 as regulators of
NCC in DCT. Another possibility is that the other WNKs, WNK1
and WNK4, compensated for the absence of WNK3 in the
NKCC2- and NCC-expressing nephrons. Considering that 1)
phosphorylation of OSR1 and SPAK at their WNK
phosphorylation sites was not lower in the kidneys of WNK3
knockout mice, and 2) WNK1 and WNK4 expression levels were
slightly higher in the kidneys of WNK3 knockout mice, it is
possible that WNK1 and WNK4 compensated for the absence of
WNK3. Therefore, the lack of phenotype in the absence of
WNK3 in the mouse kidney does not necessarily exclude a
potential role for WNK3 in activation of NCC and NKCC2 in
vivo. On the other hand, WNK4 hypomorphic mice showed
decreased phosphorylation of NCC and lower blood pressure, and
other WNKs could not compensate (Ohta et al., 2009). Therefore,
as the absence of WNK3 is compensated for by other WNKs, the
role of WNK3 in the regulation of NKCC2 and NCC in vivo may
not be substantial. To clarify this issue further, WNK3 and
WNK4 double-knockout mouse would be required; however, we
have not obtained conditional WNK4 knockout mice to date.
Fig. 5. Expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice under normal diet. (A) Representative immunoblots of
total- and phosphorylated- NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice. (B) Densitometry analyses of expression and phosphorylation of
NKCC2 and NCC in kidney from wild-type and WNK3 knockout mice. For densitometry analysis, values (n515) are expressed as ratios against the average of
signals in the wild-type group. There were no significant decreases in the expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout
mice, as compared to wild-type littermates. (C) Representative immunoblots of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice. (D)
Densitometry analyses of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3 knockout mice. For densitometry analysis, values (n515) are expressed as
ratios against the average of signals in the wild-type group. There were no significant decreases in phosphorylation of OSR1 and SPAK in kidneys from WNK3
knockout mice, as compared to wild-type littermates. n.s. not significant.
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Fig. 6. Expression and phosphorylation of NKCC2 and NCC in kidneys from WNK3 knockout mice fed low-salt diet. (A) Representative immunoblots of total
and phosphorylated NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice fed with low-salt diet. (B) Densitometry analyses of expression and
phosphorylation of NKCC2 and NCC in kidneys from wild-type and WNK3 knockout mice fed low-salt diet. For densitometry analysis, values (n510) are expressed
as ratios against the average of signals in the wild-type group. There were no significant decreases in the expression and phosphorylation of NKCC2 and NCC in
kidneys from WNK3 knockout mice, as compared to wild-type littermates, even under low-salt diet. (C) Representative immunoblots of p-OSR1 and p-SPAK in
kidneys from wild-type and WNK3 knockout mice fed low-salt diet. (D) Densitometry analyses of p-OSR1 and p-SPAK in kidneys from wild-type and WNK3
knockout mice fed low-salt diet. For densitometry analysis, values (n510) are expressed as ratios against the average of signals in the wild-type group. There were no
significant decreases in phosphorylation of OSR1 and SPAK in kidneys from WNK3 knockout mice, as compared to wild-type littermates. n.s. not significant.
Fig. 7. WNK1 and WNK4 were elevated in kidneys from WNK3 knockout mice fed low-salt diet. (A) Representative immunoblots of WNK1 and WNK4 in
kidneys from wild-type and WNK3 knockout mice fed normal diet. (B) Densitometry analyses of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout
mice fed normal diet. For densitometry analysis, values (n515) are expressed as ratios against the average of signals in the wild-type group. Expression of WNK4 was
elevated in kidneys from WNK3 knockout mice, as compared to wild-type littermates. (C) Representative immunoblots of WNK1 and WNK4 in kidneys from wild-
type and WNK3 knockout mice fed low-salt diet. (D) Densitometry analyses of WNK1 and WNK4 in kidneys from wild-type and WNK3 knockout mice fed low-salt
diet. For densitometry analysis, values (n510) are expressed as ratios against the average of signals in the wild-type group. Expression of WNK1 and WNK4 was
elevated in kidneys from WNK3 knockout mice, as compared to wild-type littermates. *P,0.05. n.s. not significant.
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WNK3 knockout mice showed lower blood pressure only
when mice were fed low-salt diet, although urinary excretion of
Na+ was not significantly affected in WNK3 knockout mice.
Indeed, consistent with urinary data, WNK3 knockout mice did
not show any decrease in expression and phosphorylation of
NKCC2 and NCC in the kidney even under low-salt diet. These
results clearly indicated that lower blood pressure in WNK3
knockout mice fed low-salt diet is not due to decreased sodium
reabsorption in the kidney, but due to the other mechanism(s).
Since WNK3 is abundantly expressed in brain, it is possible that
the absence of WNK3 in brain might affect neuronal regulatory
mechanisms of blood pressure, such as secretion of vasopressin,
control of sympathetic nerve activity, etc., although the
involvement of WNK3 in such processes has not been
investigated. It is also possible that WNK3 knockout mice
might have reduced vascular resistance since NKCC1, a substrate
of SPAK/OSR1, reportedly regulated tonus of vascular smooth
muscles, and decreased blood pressure was in fact in the NKCC1
knockout mouse (Akar et al., 2001; Meyer et al., 2002; Garg et
al., 2007). Interestingly, similar to WNK3 knockout mice,
NKCC1 knockout mice also showed lower blood pressure only
when mice were fed with low-salt diet (Kim et al., 2008).
Moreover, we recently found that SPAK knockout mice showed
the reduced aortic contractility with decreased phosphorylation of
NKCC1 (Yang et al., 2010). Accordingly, we tried to evaluate the
phosphorylation status of NKCC1 in aorta of WNK3 knockout
mice. Unfortunately, we have not yet detected an apparent
decrease of NKCC1 phosphorylation in the aorta of WNK3
knockout mice (data not shown). Since the exact quantification of
NKCC1 phosphorylation in tiny mouse aortic tissues by
immunoblot is in fact very tricky, further investigation must be
required to clarify this issue.
In this study, we generated and analyzedWNK3 knockout mice,
focusing on their renal phenotypes. However, we did not observe
any significant decreases in expression and phosphorylation of
NKCC2 and NCC in the WNK3 knockout mouse kidney. Our
results suggest that WNK3 only has a minor role in the regulation
of NKCC2 and NCC in the in vivo mouse kidney.
Materials and Methods
Targeted disruption of the Wnk3 gene
For generation of WNK3 knockout mice, we prepared the targeting vector using
PCR-amplified segments of the Wnk3 gene after verifying sequences. The
targeting vector was transfected into J1 ES cells by electroporation, as described
previously (Sohara et al., 2006). After selection with 150 mg/ml G418 and 2 mM
ganciclovir, correctly targeted ES cell clones were selected by PCR and Southern
blotting. Chimeric male mice were bred with C57BL/6 female mice to produce the
heterozygous floxed mice, and the neo cassette was then deleted by crossing the
mice with CAG-Cre recombinase-expressing transgenic mice (Sakai and
Miyazaki, 1997). Wild-type controls and WNK3 knockout mice were bred and
tail genomic DNA was applied for genotyping by PCR (forward primer; 59-
GATATGTAAGCACTACTACC-39, reverse primer-A; 59-TCTAATAGCT-
CAACTGAGTG-39, reverse primer-B; 59-GTTCTCAAGTTCTACATCTC-39).
The mice were raised in a 12-hour day and night cycle, fed with normal rodent
diet and plain drinking water. The phenotype of male mice was evaluated at the
age of 8–14 weeks. The experiment was approved by the Animal Care and Use
Committee of Tokyo Medical and Dental University.
Laser capture microdissection (LCM) and RT-PCR
For LCM, mouse kidneys were cut along the long axis and embedded in Tissue-
Tek OCT compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan) and
immediately frozen in dry ice. Tissue samples were then immersed in nitrogen
oxide. Frozen tissue blocks were cut into 10-mm sections, and were mounted on
uncoated, uncharged glass slides. Sections were stained for 20 s in Histogene
Staining Solution (Arcturus, Mountain View, CA, USA), subjected to dehydration
in a graded alcohol series, cleared for 5 min in fresh xylene, and air-dried for
5 min. LCM was performed using a Pixcell II laser capture system (Arcturus).
Tubular cells in each nephron were visualized and captured using CapSure LCM
macrocaps (Arcturus). Laser setting ranged between 70 to 90 mW in power and
0.6 to 1.0 ms in duration. Total RNA from LCM samples was extracted from
captured cells using a PicoPure RNA Isolation kit (Arcturus) and total RNA from
mouse kidneys was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA,
USA), according to the manufacturer’s instructions. Total RNA was reverse-
transcribed using Omniscript reverse transcriptase (Qiagen, Hilden, Germany). We
confirmed the presence of nephron cells using region-specific primers; NHE3
(sense; 59-GCTGTCATTGGCACTATATGG-39 (exon 2) and antisense; 59-
GAGGACTTCATTGACATGGAC-39 (exon 3)), NKCC2 ((sense; 59-AACTCA-
GTGCCCAGTAGTGC-39 (exon 2) and antisense; 59-AGGCATCCCATCT-
CCATTAG -39 (exon 3)), NCC ((sense; 59- GTCATCATGGTCTCCTTTGC -39
(exon 7) and antisense; 59-TAGCTGAGATGGCAAGGTAG-39 (exon 9)), and
ENaC a subunit (sense; 59-TCAACATTCTGTCCAGACTGC-39 (exon 3) and
antisense; 59-GTAGCATGGCCCATACATGG-39 (exon 4)). Finally, we
investigated the presence of WNK3 in these tissues; WNK3 (sense; 59-
GCTGTTGCAACTTCCCCTAGT-39 (exon 1) and antisense; 59-CCGTTGCTG-
CTCAGCTTTAG-39 (exon 2)).
Blood and urine analysis and blood pressure measurement
Blood for electrolyte analyses was obtained from the submandibular venous plexus
under light ether anesthesia. Electrolyte levels were determined with an i-STAT
analyzer (Fuso, Osaka, Japan). Mice were kept in metabolic cages for urine
collection. Low-salt (0.01% NaCl) and high-salt (4% NaCl) diets were obtained
from Oriental Yeast Co., Ltd. (Tokyo, Japan). Urine samples were analyzed by
DRI-CHEM (Fujifilm, Tokyo, Japan). Blood pressure in restrained conscious mice
at steady state was measured with a programmable tail-cuff sphygmomanometer
(MK-2000A; Muromachi, Tokyo, Japan).
Antibodies
We prepared an affinity-purified sheep antibody raised against a fragment of
recombinant mouse WNK3 (residues 1145 – 1508). Primary antibodies used in this
study were: rabbit anti-WNK1 (1:250) (Bethyl Laboratories, Montgomery, TX,
USA); rabbit anti-WNK4 (1:250) (Ohno et al., 2011); rabbit anti-phosphorylated
OSR1 (1:3000) (Ohta et al., 2009); rabbit anti-phosphorylated SPAK (1:500) (Yang
et al., 2010); rabbit anti-NHE3 (1:200) (Alpha Diagnostic, San Antonio, TX, USA);
rabbit anti-phosphorylated NCC (1:250) (Yang, S. S. et al., 2007); guinea pig anti-
NCC (1:500) (Nomura et al., 2011), rabbit anti-phosphorylated NKCC2 (1:500)
(Yang et al., 2010); rabbit anti-NKCC2 (1:1000) (kindly provided by K. Mutig,
Charite´-Universita¨tsmedizin Berlin, Campus Charite´-Mitte, Germany); and rabbit
anti-ENaC c subunit (1:250) (kindly provided by M. Knepper, National Institutes of
Health, USA). Alkaline-phosphatase-conjugated anti-IgG antibodies (Promega,
Madison, WI, USA) were used as secondary antibodies for immunoblotting.
Immunoblotting
Semiquantitative immunoblotting was performed as described previously using
whole kidney homogenates without the nuclear fraction (600 6 g) or the crude
membrane fraction (17000 6 g) (Yang, S. S. et al., 2007). Band intensity was
analyzed using Image J (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
Statistical significance was evaluated using unpaired t-test. P-values ,0.05 were
considered to be significant.
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